EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.

MLA

Tagliamento, Marco, et al. “EORTC-SPECTA Arcagen Study, Comprehensive Genomic Profiling and Treatment Adaptation of Rare Thoracic Cancers.” NPJ Precision Oncology, vol. 8, no. 1, Feb. 2024, p. 37. EBSCOhost, https://doi.org/10.1038/s41698-024-00518-9.

APA

Tagliamento, M., Morfouace, M., Loizides, C., Oliveira, J., Greillier, L., Raimbourg, J., Toffart, A.-C., Chatellier, T., Cloarec, N., Sullivan, I., Brasiuniene, B., Duruisseaux, M., Oselin, K., Robert, M.-S., Fernandes, C., Poncin, A., Blay, J.-Y., Besse, B., & Girard, N. (2024). EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers. NPJ Precision Oncology, 8(1), 37. https://doi.org/10.1038/s41698-024-00518-9

Chicago

Tagliamento, Marco, Marie Morfouace, Charalambos Loizides, Julio Oliveira, Laurent Greillier, Judith Raimbourg, Anne-Claire Toffart, et al. 2024. “EORTC-SPECTA Arcagen Study, Comprehensive Genomic Profiling and Treatment Adaptation of Rare Thoracic Cancers.” NPJ Precision Oncology 8 (1): 37. doi:10.1038/s41698-024-00518-9.